The year's new drugs.
Forty-four new chemical entities and biological drugs and two diagnostic agents reached their first markets in 1999. Endocrine Drugs was the most active therapeutic group in terms of new launches, with nine market introductions, and the United States was once again the most active market for new products, with a total of 23 new launches in 1999, constituting 50% of all new introductions for the year.